Moderna Inc (MRNA)
107.80
+3.34
(+3.20%)
USD |
NASDAQ |
Apr 23, 16:00
107.58
-0.22
(-0.20%)
After-Hours: 19:02
Moderna Net Income (Quarterly): 217.00M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 217.00M |
September 30, 2023 | -3.63B |
June 30, 2023 | -1.38B |
March 31, 2023 | 79.00M |
December 31, 2022 | 1.465B |
September 30, 2022 | 1.043B |
June 30, 2022 | 2.197B |
March 31, 2022 | 3.657B |
December 31, 2021 | 4.868B |
September 30, 2021 | 3.333B |
June 30, 2021 | 2.78B |
March 31, 2021 | 1.221B |
December 31, 2020 | -273.00M |
Date | Value |
---|---|
September 30, 2020 | -233.00M |
June 30, 2020 | -117.00M |
March 31, 2020 | -124.00M |
December 31, 2019 | -123.27M |
September 30, 2019 | -123.22M |
June 30, 2019 | -134.94M |
March 31, 2019 | -132.58M |
December 31, 2018 | -141.43M |
September 30, 2018 | -80.33M |
June 30, 2018 | -90.60M |
March 31, 2018 | -72.38M |
December 31, 2017 | -37.94M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-3.63B
Minimum
Sep 2023
4.868B
Maximum
Dec 2021
774.82M
Average
79.00M
Median
Mar 2023
Net Income (Quarterly) Benchmarks
Merck & Co Inc | -1.226B |
Pfizer Inc | -3.369B |
Eli Lilly and Co | 2.190B |
Johnson & Johnson | 5.354B |
Novavax Inc | -178.39M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 2.813B |
Total Expenses (Quarterly) | 2.807B |
EPS Diluted (Quarterly) | 0.55 |
Enterprise Value | 31.39B |
Gross Profit Margin (Quarterly) | 66.97% |
Profit Margin (Quarterly) | 7.71% |
Earnings Yield | -11.51% |
Normalized Earnings Yield | -11.38 |